Kestra Medical Technologies Ltd Quick Ratio (KMTS) starting from the first quarter 2026 to first quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Kestra Medical Technologies Ltd   (NASDAQ: KMTS)

Kestra Medical Technologies Ltd 's Quick Ratio

KMTS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Kestra Medical Technologies Ltd 's Cash & cash equivalent grew by 1.26 % in the Q1 2026 sequentially, while Current Liabilities decreased, this led to improvement in Kestra Medical Technologies Ltd 's Quick Ratio to 4.12, above Kestra Medical Technologies Ltd average Quick Ratio.

Within Medical Equipment & Supplies industry 45 other companies have achieved higher Quick Ratio than Kestra Medical Technologies Ltd in first quarter 2026. While Quick Ratio total ranking in the first quarter 2026 has deteriorated compared to the prior quarter from 626 to 1075.

Explain Quick Ratio?
How much Cash & cash equivalents KMTS´s has?
What are KMTS´s Current Liabilities?




KMTS Quick Ratio (Jul 31 2026)
Q1
(Apr 30 2026)
Q4
(Jan 31 2026)
Q3
(Oct 31 2025)
Q2
(Jul 31 2025)
Q1
Y / Y Current Liabilities Change 49.81 % 33.29 % - 8.29 % -
Y / Y Cash & cash equivalent Change -1.14 % -17.32 % - 2026.61 % -
Quick Ratio MRQ 4.12 3.9 0.25 4.91 6.25
KMTS's Total Ranking # 1075 # 626 # 463 # 565 # 0
Seq. Current Liabilities Change -4.17 % 52.78 % -7.65 % 10.81 % -14.74 %
Seq. Cash & cash equivalent Change 1.26 % 2281.31 % -95.3 % -12.82 % -15.31 %



Quick Ratio first quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 46
Healthcare Sector # 364
Overall Market # 1075


Quick Ratio Statistics
High Average Low
6.29 3.71 0.25
(Apr 30 2025)   (Apr 30 2024)




Financial Statements
Kestra Medical Technologies Ltd 's Current Liabilities $ 48 Millions Visit KMTS's Balance sheet
Kestra Medical Technologies Ltd 's Cash & cash equivalent $ 199 Millions Visit KMTS's Balance sheet
Source of KMTS's Sales Visit KMTS's Sales by Geography


Cumulative Kestra Medical Technologies Ltd 's Quick Ratio

KMTS's Quick Ratio for the trailling 12 Months

KMTS Quick Ratio

(Jul 31 2026)
12 Months
(Apr 30 2026)
12 Months
(Jan 31 2026)
12 Months
(Oct 31 2025)
12 Months
(Jul 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth 62.47 % 113.77 % 320.62 % 220.62 % -
Y / Y Cash & cash equivalent TTM Growth 29.52 % 136.46 % 7446.15 % 7346.15 % -
Quick Ratio TTM 3.46 3.84 4.49 5.81 4.34
Total Ranking TTM # 4432 # 4291 # 0 # 0 # 0
Seq. Current Liabilities TTM Growth 10.61 % 9.07 % 31.19 % 2.65 % 45.53 %
Seq. Cash & cash equivalent TTM Growth -0.4 % -6.61 % 1.34 % 37.39 % 81.85 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the Q1 2026 to $48.27 millions, cumulative Quick Ratio decreased to 3.46 above the KMTS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 213 other companies have achieved higher Quick Ratio than Kestra Medical Technologies Ltd . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2026 from 4291 to 4432.

Explain Quick Ratio?
How much Cash & cash equivalents KMTS´s has?
What are KMTS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 214
Healthcare Sector # 980
Within the Market # 4432


trailing twelve months Quick Ratio Statistics
High Average Low
3.2 2.65 2.1
(Apr 30 2026)   (Jul 31 2026)




Companies with similar Quick Ratio in the quarter ending Jul 31 2026, within Medical Equipment & Supplies Industry Quick RatioJul 31 2026 MRQ Cash & cash equivalentJul 31 2026 MRQ Current Liabilities
Pulse Biosciences Inc   9.26 $ 101.620  Millions$ 10.978  Millions
Orchestra Biomed Holdings Inc   8.16 $ 109.963  Millions$ 13.471  Millions
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions

Date modified: 2026-09-15T11:55:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.